Navigation Links
Increased Capacity For Porcine Liver Esterase
Date:6/6/2008

ST. LOUIS, June 6 /PRNewswire/ -- Lee Biosolutions, Inc, a worldwide supplier for porcine liver esterase has announced it has increased its capacity to an industrial scale of over 150 million units per batch size.

Lee Biosolutions supplies Porcine Liver Esterase and other stable high purity enzymes and related proteins to major diagnostic companies used in urine tests as an indicator of blood or urine infection. Porcine liver esterase is also used on a large commercial scale as a biocatalyst in the resolution of mixtures of chiral esters by hydrolysis to produce optically active carboxylic acids.

Lee Biosolutions growth for porcine liver esterase is attributed to meeting stringent customer specifications while maintaining consistent high quality products that out perform other manufacturers on the market. Lee Biosolutions scientific team operates with built-in flexibility, is able to respond in a timely manner and has some of the best scientists working in this industry.

According to Lee Biosolutions President Burton Lee, porcine liver esterase demand has increased significantly over the past 12 months. "We operate with one ear constantly tuned to the diagnostic manufacturing and pharmaceutical community," Lee said. "This helps us stay on top of the latest research being conducted on hydrolase enzymes such as porcine liver esterase and gives us the information we need to stay ahead of their demands."

Lee Biosolutions is a leader in the biomarker industry, providing quality products such as http://www.leebio.com/esterase-porcine-P122 (porcine liver esterase) to clinical labs and researchers around the world, developing tomorrow's cures. For more information on porcine esterase and our capabilities go to http://www.leebio.com or contact:

Press Release Contact Information:

Burton Lee

President

Lee Biosolutions, Inc

314.968.1091

info@leebio.com

This release was issued through WebWire(R). For more information visit http://www.webwire.com.


'/>"/>
SOURCE Lee Biosolutions, Inc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis
2. Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc.
3. Nephrologists and Non-Nephrologists Alike Report Increased Attention on Chronic Kidney Disease
4. LifeStem International, Inc. Announces Increased Revenues, Decreased Operating Expenses
5. Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates
6. Increased Light Leads to Early Detection: Caliper Life Sciences Introduces Bioware(R) Ultra Cancer Cell Lines
7. APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs)
8. Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
9. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
10. AMTs Cooperative Research and Development Agreement With NIH to Boost Production Capacity
11. Dragon announces new product launch; increase in annual production output capacity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... India , Jan. 19, 2017  Market Research Future has ... Global Market for Liquid Biopsy is growing rapidly and expected to ... Market Highlights ... The Global Liquid Biopsy Market has been assessed as a ... growth figures and boom in the coming future. There has been ...
(Date:1/19/2017)... , Jan 19, 2017 Research and Markets ... has announced the addition of ... Material, Application - Forecast to 2025" report to their ... The report provides a detailed analysis on current and ... forecasts till 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , Jan. ... and Altimmune, Inc., a privately-held immunotherapeutics company targeting ... definitive agreement for the merger of PharmAthene and ... include Novartis Venture Fund, HealthCap, Truffle Capital and ... fully-integrated and diversified immunotherapeutics company with four clinical ...
(Date:1/19/2017)... ... January 18, 2017 , ... The ... (NIH) to update its Data Sharing Policy. Specifically, the nation’s leading informatics experts, ... subject to the existing policy. AMIA recommended that NIH earmark funding for researchers ...
Breaking Biology Technology:
(Date:1/18/2017)... , Jan. 18, 2017 ... company that supports the entire spectrum of clinical ... been another record-breaking year for the organization in ... interest in MedNet,s eClinical products and services. The ... tremendous marketplace success of iMedNet ...
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/11/2017)... NEW BRUNSWICK, N.J. , Jan. 11, 2017  Michael Johnson, ... from Foundation Venture Capital Group, Inc., has been named to the ... Johnson, 27,  was one of 600 people in 20 fields ... only four percent of the 15,000 applicants were selected. ... He is currently a PhD ...
Breaking Biology News(10 mins):